90 related articles for article (PubMed ID: 8684295)
1. An updated evaluation of reported no-observed adverse effect levels for chrysotile, amosite, and crocidolite asbestos for lung cancer and mesothelioma.
Beckett EM; Abelmann A; Roberts B; Lewis RC; Cheatham D; Miller EW; Hall E; Pierce JS
Crit Rev Toxicol; 2023 Nov; 53(10):611-657. PubMed ID: 38126124
[TBL] [Abstract][Full Text] [Related]
2. The case for a global ban on asbestos.
LaDou J; Castleman B; Frank A; Gochfeld M; Greenberg M; Huff J; Joshi TK; Landrigan PJ; Lemen R; Myers J; Soffritti M; Soskolne CL; Takahashi K; Teitelbaum D; Terracini B; Watterson A
Environ Health Perspect; 2010 Jul; 118(7):897-901. PubMed ID: 20601329
[TBL] [Abstract][Full Text] [Related]
3. Asbestos in High-Risk Communities: Public Health Implications.
Emmett EA
Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33562413
[TBL] [Abstract][Full Text] [Related]
4. Asbestos surface provides a niche for oxidative modification.
Nagai H; Ishihara T; Lee WH; Ohara H; Okazaki Y; Okawa K; Toyokuni S
Cancer Sci; 2011 Dec; 102(12):2118-25. PubMed ID: 21895868
[TBL] [Abstract][Full Text] [Related]
5. A cluster of mesotheliomas reported in a case series does not implicate chrysotile asbestos-containing friction products as the cause of mesotheliomas.
Geyer SJ
Am J Ind Med; 2024 Jan; 67(1):81-82. PubMed ID: 38032359
[No Abstract] [Full Text] [Related]
6. EPA ruling to ban chrysotile asbestos.
Burki T
Lancet Oncol; 2024 May; 25(5):537. PubMed ID: 38522452
[No Abstract] [Full Text] [Related]
7. Ongoing downplaying of the carcinogenicity of chrysotile asbestos by vested interests.
Baur X; Frank AL
J Occup Med Toxicol; 2021 Feb; 16(1):6. PubMed ID: 33622366
[TBL] [Abstract][Full Text] [Related]
8. Exposure hazards from continuing use and removal of asbestos cement products.
Gottesfeld P
Ann Work Expo Health; 2024 Jan; 68(1):8-18. PubMed ID: 37950621
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma.
Pierce JS; McKinley MA; Paustenbach DJ; Finley BL
Crit Rev Toxicol; 2008; 38(3):191-214. PubMed ID: 18324516
[TBL] [Abstract][Full Text] [Related]
10. Chrysotile and crocidolite asbestos in Israel: uses, exposures and risks.
Richter ED; Berdugo M; Laster R; Westin JB; Fischbein A
Med Lav; 1995; 86(5):449-56. PubMed ID: 8684295
[TBL] [Abstract][Full Text] [Related]
11. Recent data on cancer due to asbestos in the U.S.A. and Denmark.
Nicholson WJ; Raffn E
Med Lav; 1995; 86(5):393-410. PubMed ID: 8684290
[TBL] [Abstract][Full Text] [Related]
12. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure.
Hodgson JT; Darnton A
Ann Occup Hyg; 2000 Dec; 44(8):565-601. PubMed ID: 11108782
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
Gamble JF; Gibbs GW
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
[TBL] [Abstract][Full Text] [Related]
14. Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
